insights_auto
Why is NOV up ၂.၇၆%?
Dive Deeperchevron_right
NOV:ETR
Novo Nordisk A/S
၃၅.၃၂ €
arrow_upward
+၂.၇၆%(+၀.၉၅) 1D
အောက် ၁၅, GMT+၂ ၁၇:၃၅:၃၈ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOV...
Open
၃၄.၂၆ €
High
၃၅.၃၆ €
Low
၃၄.၁၉ €
Mkt. cap
ဋေ ၁.၃၅ သ
Avg. vol.
၁.၇၈ သိန်း
Volume
၂.၂၀ သိန်း
52-wk high
၅၄.၈၇ €
52-wk low
၃၀.၂၄ €
No. of employees
၇ သောင်း
Open
၃၄.၂၆ €
High
၃၅.၃၆ €
Low
၃၄.၁၉ €
Mkt. cap
ဋေ ၁.၃၅ သ
Avg. vol.
၁.၇၈ သိန်း
Volume
၂.၂၀ သိန်း
52-wk high
၅၄.၈၇ €
52-wk low
၃၀.၂၄ €
No. of employees
၇ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၈ နာရီ
Novo Nordisk stock gains 1.12 percent ahead of November 4 results
Traders Union
·
ပြီးခဲ့သည့် ၉ နာရီ
Novo Nordisk stock consolidates amid seller pressure near $38.39 resistance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Novo Nordisk (NVO) Could Be 63% Undervalued Following Its Share Buyback
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Is Novo Nordisk (NYSE:NVO) A Long Term Value Opportunity Now?
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees၆.၆၇ သောင်း
Founded၁၉၂၃
HeadquartersBagsværd, Capital Region of Denmark, ဒိန်းမတ်
Sector-
Websitenovonordisk.com